ST. CATHARINES, Ontario - TelAve -- Cedience, the regulatory-first AI company supporting drug development teams with innovative research and intelligence technology, today announced the launch of Cedience Labs, a new platform enabling teams to experiment with cutting-edge, AI-powered tools that support decision-making at critical points in drug development.

Cedience Labs provides a secure environment where regulatory teams can explore advanced AI capabilities—particularly large language model (LLM) technologies—without disrupting existing processes or enterprise systems. The platform reflects Cedience's commitment to enabling regulatory organizations to modernize their toolkits with a value-first approach, grounded in real-world regulatory use cases.

"The biopharmaceutical industry is rapidly adopting AI and LLM-based technologies, with many enterprise-wide initiatives well underway," said Amin Osmani, CEO of Cedience. "Cedience Labs was created to give regulatory professionals a practical way to engage with these innovations without delay—allowing them to enhance their workflows, not replace them."

More on TelAve News

• Aleen Inc. (C S E: ALEN.U) Advances Digital Wellness Vision with Streamlined Platform Navigation and Long-Term Growth Strategy
• RimbaMindaAI Officially Launches Version 3.0 Following Strategic Breakthrough in Malaysian Market Analysis
• Fed Rate Pause & Dow 50k: Irfan Zuyrel on Liquidity Shifts, Crypto Volatility, and the ASEAN Opportunity
• 20/20 Institute Launches Updated Vision Correction Procedures Page for Denver & Colorado Springs
• OneVizion Announces Next Phase of Growth as Brad Kitchens Joins Board of Directors

Re-inventing the Regulatory Toolbox

Regulatory teams face increasing complexity as global health authorities and their guidelines or requirements evolve with the industry. Cedience Labs addresses this challenge by enabling hands-on experimentation with AI-driven tools that align with how regulatory work is actually performed.

Through Cedience Labs, regulatory professionals can explore AI-supported workflows such as:

• Monitoring and interpreting changes in the global regulatory environment
• Assessing the potential impact of regulatory updates
• Establishing regulatory precedents across indications, regions, and products
• Preparing for agency meetings and interactions
• Analyzing and benchmarking regulatory review timelines

All workflows are designed to integrate seamlessly into existing regulatory processes, allowing teams to enhance efficiency and insight without operational disruption.

Built for Today's AI-Enabled Enterprise

As AI adoption accelerates across biopharma, Cedience Labs offers a pragmatic bridge between experimentation and enterprise readiness. The platform enables regulatory teams to evaluate emerging AI capabilities, understand their value, and build confidence before broader organizational deployment.

More on TelAve News

• New Children's Picture Book "Diwa of Mount Luntian" Focuses on Calm, Culture, and Connection for Today's Families
• Actor, Spokesperson Rio Rocket Featured in "Switch to AT&T" Campaign Showing How Customers Can BYOD and Keep Their Number
• The World's No.1 Superstar® Brings Disco Fever Back With New Global Single and Video "Disco Dancing"
• Boston Industrial Solutions' Natron® 512N Series UV LED Ink Achieves BPA Certification, Advancing Safe and Sustainable Digital Printing
• Joan Nissen promoted to Century Fasteners Corp. – General Manager, Aerospace & Government Sales

"Our team has built the AI building blocks regulatory teams need to capture the value from LLMs without complex development cycles," said Andy Nanopoulos, CTO of Cedience. "Cedience Labs provides modular, workflow-ready components that can be applied directly to real regulatory questions, allowing teams to move from experimentation to impact quickly and responsibly."

By abstracting the complexity of large language models and embedding them into familiar regulatory workflows, Cedience Labs helps organizations realize value from AI while maintaining governance, traceability, and alignment with existing operating models. Regulatory teams can incrementally enhance their capabilities, test new approaches, and scale successful use cases at their own pace.

For more information about Cedience and its regulatory intelligence solutions, visit www.cedience.com